TTS is characterized by blood clots (thrombosis) combined with low levels of platelets (thrombocytopenia), which are necessary for blood clotting. It often involves unusual blood clot locations, such as in the brain (cerebral venous sinus thrombosis) or abdomen. Symptoms of TTS may include Severe or persistent headaches blurred vision Shortness of breath Chest pain Leg swelling Persistent abdominal pain Easy bruising or tiny blood spots under the skin beyond the injection site Though TTS is rare, it is important for individuals who have received vaccines associated with TTS to be aware of the symptoms and seek medical attention if they experience any of them within a few weeks of vaccination.
Early recognition and treatment are crucial for managing TTS effectively. "TTS, or thrombosis with thrombocytopenia syndrome, involves blood clots in the brain or other parts of the body, along with a low platelet count. It's a rare occurrence following specific types of vaccines and other causes.
According to the WHO, adenovirus vector vaccines, in particular, have been rarely associated with this condition," Dr. Jayadevan, Co-Chairman of the National Indian Medical Association (IMA) Covid Task Force in Kerala told ANI. "While Covid vaccines have undoubtedly saved lives, reports of these extremely rare but potentially serious immune-mediated events have also been documented in reputable journals," Dr.
Jayadevan added. According to a report from The Telegraph, AstraZeneca, the pharmaceutical giant, has acknowledged that its COVID-19 vaccine can lead to a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS). According to a 2023 report on yalemedicine.org, a blood clot is essentially a gel-like clump of blood.
Read more on livemint.com